TipRanks
Advertisement
Advertisement

MX:ACAD Stock Latest News

Acadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
Company AnnouncementsAcadia Pharmaceuticals Reaches Preliminary Derivative Lawsuit Settlement
4d ago
8K
ACAD
Acadia Pharmaceuticals price target raised to $38 from $37 at Deutsche Bank
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $38 from $37 at Deutsche Bank
21d ago
ACAD
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
PremiumRatings
ACADIA: EU Orphan Drug Launch Underscores Pricing Strength; Buy Rating and $37 Price Target Reaffirmed
21d ago
ACAD
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
PremiumRatings
ACADIA: Buy Rating Reiterated as Daybue Momentum Builds and Key Pipeline Catalyst Nears; Price Target Maintained at $36
21d ago
ACAD
Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley
21d ago
ACAD
Analyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
PremiumRatingsAnalyst Lifts ACADIA Price Target to $40 on Favorable Risk‑Reward and RADIANT Alzheimer’s Psychosis Upside
21d ago
ACAD
Acadia Pharmaceuticals price target raised to $40 from $39 at Citi
Premium
The Fly
Acadia Pharmaceuticals price target raised to $40 from $39 at Citi
21d ago
ACAD
Acadia Pharmaceuticals announces EC marketing authorization for Daybu
Premium
The Fly
Acadia Pharmaceuticals announces EC marketing authorization for Daybu
22d ago
ACAD
Acadia Pharmaceuticals price target raised to $49 from $45 at UBS
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $49 from $45 at UBS
29d ago
ACAD
Acadia Pharmaceuticals price target raised to $41 from $38 at Needham
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $41 from $38 at Needham
29d ago
ACAD
ACADIA Pharmaceuticals: Buy Rating Reiterated on Undervalued Growth Story; $36 Price Target Unchanged
PremiumRatings
ACADIA Pharmaceuticals: Buy Rating Reiterated on Undervalued Growth Story; $36 Price Target Unchanged
1M ago
ACAD
ACADIA Pharmaceuticals Earnings Call Signals Growth Momentum
PremiumCompany Announcements
ACADIA Pharmaceuticals Earnings Call Signals Growth Momentum
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $27 from $26 at Morgan Stanley
PremiumThe FlyAcadia Pharmaceuticals price target raised to $27 from $26 at Morgan Stanley
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $39 from $35 at Citi
Premium
The Fly
Acadia Pharmaceuticals price target raised to $39 from $35 at Citi
1M ago
ACAD
ACADIA: Buy Rating Reiterated as Analyst Sees Favorable Risk-Reward Ahead of RADIANT Readout; $37 Price Target Unchanged
Premium
Ratings
ACADIA: Buy Rating Reiterated as Analyst Sees Favorable Risk-Reward Ahead of RADIANT Readout; $37 Price Target Unchanged
1M ago
ACAD
Acadia Pharmaceuticals: Buy Rating Reiterated as Growth Drivers Strengthen; Price Target Maintained at $36
PremiumRatings
Acadia Pharmaceuticals: Buy Rating Reiterated as Growth Drivers Strengthen; Price Target Maintained at $36
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $31 from $30 at BofA
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $31 from $30 at BofA
1M ago
ACAD
ACADIA: Hold Rating Reaffirmed as Strong Daybue Sales Drive FY26 Guidance Raise; $26 Price Target Maintained
PremiumRatings
ACADIA: Hold Rating Reaffirmed as Strong Daybue Sales Drive FY26 Guidance Raise; $26 Price Target Maintained
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $25 from $23 at Oppenheimer
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $25 from $23 at Oppenheimer
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $37 from $36 at RBC Capital
PremiumThe FlyAcadia Pharmaceuticals price target raised to $37 from $36 at RBC Capital
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $36 from $35 at Mizuho
Premium
The Fly
Acadia Pharmaceuticals price target raised to $36 from $35 at Mizuho
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $36 from $35 at Citizens
Premium
The Fly
Acadia Pharmaceuticals price target raised to $36 from $35 at Citizens
1M ago
ACAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >